Dr. Fecteau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Duke Medicine Cir
BOX 3085
Durham, NC 27710Phone+1 919-668-5640Fax+1 919-668-7345
Summary
- Ryan Fecteau, MD, is a radiation oncologist specializing in urologic cancer, currently based in Durham, NC. He completed his residency in radiation oncology at Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital, with an internship at Case Western Reserve University/University Hospitals Cleveland Medical Center. Dr. Fecteau serves as a medical instructor and radiation oncologist at Duke University Medical Center. His recent publications include studies on prostate cancer, genetic risk factors for cancer, and the impact of treatment techniques, with citations in reputable journals such as Prostate Cancer and Prostatic Diseases, Gastroenterology, and JAMA Oncology.
Education & Training
- Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2021 - 2022
- New York-Presbyterian Hospital (Cornell Campus)Residency, Radiation Oncology, 2018 - 2021
- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Preliminary Year, 2017 - 2018
- Case Western Reserve University School of MedicineClass of 2017
Certifications & Licensure
- NC State Medical License 2022 - 2026
- NY State Medical License 2021 - 2023
- OH State Medical License 2017 - 2020
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.Ryan E Fecteau, Bridget F Koontz, Karen E Hoffman, Susan Halabi, Lauren E Howard
Prostate Cancer and Prostatic Diseases. 2024-02-22 - 1 citationsGenetic Defect in Submucosal Gland-Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk.Katherine S Garman, Biswa P D Purkayastha, Joyce A Hogue, Ryan Fecteau,
Gastroenterology. 2023-12-01 - The importance of body composition in patients with prostate cancer receiving radiotherapy.Ryan Fecteau, W Robert Lee
Cancer. 2023-03-01
Press Mentions
- Bill to Improve Dental Health Access Passes Unanimously in LegislatureJune 4th, 2021
- Expanding Access to Dental Care Is Good for Mainers and the EconomyApril 6th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: